Загрузка...
Utility of chromogranin B compared with chromogranin A as a biomarker in Japanese patients with pancreatic neuroendocrine tumors
OBJECTIVE: Currently, serum chromogranin A is a well-established biomarker for pancreatic neuroendocrine tumors; however, other pancreatic diseases, oral use of a proton pump inhibitor and renal impairment can affect chromogranin A. Meanwhile, chromogranin B, belonging to the same granin family as c...
Сохранить в:
| Опубликовано в: : | Jpn J Clin Oncol |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6283109/ https://ncbi.nlm.nih.gov/pubmed/28334992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyx032 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|